Adrenergic Cholinergic Enteric Measures/Mapping
Part of paid clinical trials in Louisville, Kentucky.
- Sponsor
- University of Louisville
- Study ID
- NCT04013282
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
Patients seen who had autonomic and enteric profiling (Adrenergic, Cholinergic, Enteric Measures/Mapping=ACEM\_ from 2012-2019 at the University of Louisville.
Key Dates
- Start date
- Oct 1, 2012
- Status verified
- Jan 2025
- Primary completion
- Oct 1, 2025
- Completion
- Oct 1, 2025
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Body Mass Index [ Time Frame: 10 years ]
Central Contacts
- Thomas L Abell(502)852-6991
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Louisville | Louisville | Kentucky | 40202 | Thomas Abell, MD |
Find similar trials in Louisville, KY
By condition
By specialty
By research site
Related Studies
- The Effects of Mirabegron and Tadalafil on Glucose Tolerance in PrediabeticsPHASE4 · Recruiting · Philip Kern · Lexington, Kentucky
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightPHASE2 · Recruiting · Eli Lilly and Company · Chandler, Arizona
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityPHASE3 · Recruiting · Amgen · Daphne, Alabama
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPHASE3 · Recruiting · Amgen · Birmingham, Alabama